Showing results (411-420 of 450) with videos related to
Sort By:
Pageof 45
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2019
Modulation of Target Antigen Density Improves CAR T-cell Functionality and PersistenceSneha Ramakrishna, Steven L Highfill, Zachary Walsh, et al.Molecular Cell|April 22, 2020
MYC Controls the Epstein-Barr Virus Lytic SwitchRui Guo, Chang Jiang, Yuchen Zhang, et al.Nature Medicine|May 5, 2015
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsAdrienne H Long, Waleed M Haso, Jack F Shern, et al.Journal for Immunotherapy of Cancer|May 9, 2022
Efficacy of second CAR-T (CART2) infusion limited by poor CART expansion and antigen modulationElizabeth M Holland, John C Molina, Kniya Dede, et al.The Journal of Infectious Diseases|January 7, 1998
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study GroupJ E Feinberg, S Hurwitz, D Cooper, et al.Pediatric Blood & Cancer|January 26, 2020
Disease detection methodologies in relapsed B-cell acute lymphoblastic leukemia: Opportunities for improvementHaneen Shalabi, Constance M Yuan, Amita Kulshreshtha, et al.Blood|October 6, 2022
Murine allogeneic CAR T cells integrated before or early after posttransplant cyclophosphamide exert antitumor effectsMichael T Patterson, Shanzay M Khan, Natalia S Nunes, et al.Nature Communications|April 10, 2023
Hypoimmune anti-CD19 chimeric antigen receptor T cells provide lasting tumor control in fully immunocompetent allogeneic humanized miceXiaomeng Hu, Karl Manner, Rowena DeJesus, et al.Blood|December 3, 2014
Acute GVHD in patients receiving IL-15/4-1BBL activated NK cells following T-cell-depleted stem cell transplantationNirali N Shah, Kristin Baird, Cynthia P Delbrook, et al.Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Chimeric Antigen Receptor T-Cell TherapyNdiya Ogba, Nicole M Arwood, Nancy L Bartlett, et al.Pageof 45